A researcher at Queen's University has found that measuring the levels of a natural body chemical may allow clinicians to better guide antibiotic use and improve the health outcomes of critically ill patients.
"Infection is a common and expensive complication of critical illness and were trying to find ways to improve the outcomes of sick, elderly patients and, at the same time, reduce healthcare costs," says Daren Heyland, a professor of Medicine at Queens, director of the Clinical Evaluation Research Unit at Kingston General Hospital, and scientific director of the Technology Evaluation in the Elderly Network.
Prolonged antibiotic exposure is associated with an increase in drug-resistant pathogens. It makes sense, according to Heyland, to examine ways in which we might make the duration of antibiotic treatment more precise without compromising patient outcome.
Heyland and Queens research colleagues John Muscedere (School of Medicine) and Ana Johnson (Department of Community Health and Epidemiology) conducted a review of five different studies and found that measuring levels of the chemical procalcitonin (PCT) may be an effective way to monitor the presence of an infection and guide the duration of antibiotic treatment. This is because levels of PCT in the body rise in response to an infection and fall in response to sufficient antibiotic treatment.
The researchers found that using PCT levels to guide antibiotic use means that a course of antibiotics can, on average, be reduced by two days without affecting patient health or length of stay in the intensive care unit. This reduction was also found to be associated with a $470 saving per treatment course ($CDN, 2009). Since infections like ventilator-associated pneumonia are fairly common in hospital intensive care units, this saving on individual treatment courses could translate into significant savings in overall healthcare costs.
"This study is an example of the kind of technology evaluation that is so important to do, to inform clinicians and health care decision makers how to achieve best patient outcomes with the least costs," adds Johnson.
These findings were recently published in Critical Care Medicine.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.